That's the core tension researchers face when choosing between IGF-1 LR3 and Tesamorelin + Ipamorelin blends: one compound delivers immediate, systemic IGF receptor activation
Treatment typically starts with 0.75 mg once weekly, with possible dose increases at intervals of at least 4 weeks if additional glycaemic control is needed
People with higher proportions of visceral fat, which is more metabolically active and responsive to hormonal signals, often see more dramatic early changes than those carrying primarily subcutaneous fat
Both compounds hold promise in supporting metabolic health and providing antioxidant protection, and while current research suggests they can be taken together, individual responses may vary
Understanding which foods and nutrients have the strongest effect allows you to structure meals that naturally optimise this important metabolic hormone
When patients feel connected to their care team, long-term success becomes far more achievable